Key Highlights
- UnitedHealth delivered Q2 adjusted EPS of $6.38, significantly exceeding the $4.91 Wall Street consensus
- Quarterly revenue totaled $112 billion, surpassing analyst expectations of $110.8 billion
- Company elevated full-year adjusted EPS guidance to $19.50–$20.00 range
- Medical-cost ratio decreased to 86.7%, improving from 89.4% in the prior-year period
- Competitor health insurers including Humana, Centene, and Molina climbed in premarket activity
Shares of UnitedHealth Group climbed approximately 7% during premarket hours Thursday following the healthcare giant’s announcement of second-quarter financial results that exceeded Wall Street projections and an upward revision to its annual forecast.
UnitedHealth Group Incorporated, UNH
The company’s adjusted profit reached $6.38 per share, substantially outpacing analyst expectations of roughly $4.85–$4.91. This represents an earnings surprise of more than $1.50 per share — a significant margin of outperformance.
Quarterly revenue totaled $112 billion, exceeding Wall Street’s projection of $110.8 billion. This marks an increase from $111.6 billion recorded during the comparable quarter last year.
The healthcare provider’s medical-cost ratio — representing the portion of premium revenue allocated to medical claims — declined to 86.7%. This reflects an improvement from 89.4% in Q2 2025 and outperformed the 88.4% analyst projection. Company leadership attributed the enhancement to adjustments in benefit structures, more disciplined pricing strategies, and improved oversight of medical expenditures.
Operating earnings surged to $8.0 billion, climbing from $5.2 billion during the second quarter of 2025.
Annual Outlook Elevated
Capitalizing on the robust quarterly performance, UnitedHealth increased its 2026 full-year adjusted earnings outlook to a span of $19.50 to $20.00 per share. The $19.75 midpoint substantially exceeds the analyst consensus of $18.48–$18.49. The company’s prior guidance had established a floor of $18.25.
Management also boosted its annual cash flow projection to approximately $24 billion, up from the previous target of over $18 billion.
Operating cash flows totaled $11.1 billion during the quarter, representing 1.9 times net income. The company has already executed $4 billion in share repurchases through mid-July and anticipates buying back a minimum of $5 billion throughout the full year.
Business Unit Performance
UnitedHealthcare provided coverage to 48.5 million members throughout the quarter and posted revenues of $86 billion alongside earnings of $3.9 billion. The division’s operating margin widened to 4.6%, expanding from 2.4% in Q2 2025.
Optum, the organization’s healthcare services division, delivered revenues of $65.7 billion and earnings of $4.0 billion, demonstrating 160 basis points of year-over-year margin improvement.
Chief Executive Stephen Hemsley noted the results demonstrate “continuing progress in our work to simplify how we operate, improve both affordability and the health care experience for patients and care providers.”
The impressive financial performance also provided momentum to rival health insurance companies. Humana climbed 4.8% during premarket trading, while Centene advanced 4.6% and Molina Healthcare increased 2.9%.
UnitedHealth’s premarket surge of roughly 7% pushed shares toward $448.50, compared with the previous closing price of approximately $418.52.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
